Skip to main content

Closed

INBX: Inhibrx Biosciences Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-88.9% / yr

Operating margin-9465.5%

ROIC-77.0%

Financially safe

Stretched

Debt / equity-0.28×

Interest coverage-9.5×

Current ratio6.46×

Inhibrx Biosciences Inc.

INBXNASDAQ·USD·Closed

Inhibrx Biosciences Inc.

INBXNASDAQ·USD·Closed

$82.05

−3.16%

$82.05

−$2.68 (3.16%)

52W Range

46thpctl

Volume

0.28×avg

Mkt Cap

1.20BUSD

P/E

-9.8TTM

Div Yield

–ann

52W Range

46thpctl

Volume

0.28×avg

Market Cap

1.20BUSD

P/E Ratio

-9.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings